Aimed Alliance recently submitted letters of support to the Washington and Iowa legislatures urging them to swiftly pass biomarker legislation…
The New York Assembly and Senate have officially adjourned until 2024, and Aimed Alliance is thrilled to share that several…
On June 2, 2022, Aimed Alliance released a new fact sheet on biomarker testing titled “Increase Access to Precision Medicine…
On May 10, 2022, Aimed Alliance launched two new maps to track active and enacted biomarker legislation. Biomarker testing can…